Live tape
Top 8, mentions 7d14,352NVDA4,863 mentions▲ +0.04GOOGL2,061 mentions▲ +0.04SPY1,738 mentions▲ +0.06QQQ1,554 mentions▲ +0.05AMD1,212 mentions▲ +0.08SPCX1,108 mentions▲ +0.05TSLA954 mentions▲ +0.04SNDK862 mentions▲ +0.06

Equity · Healthcare

PRCT

NASDAQ

PROCEPT BioRobotics (PRCT)

19 USD −2.41% vs prior close Sep 18, 2026
PROCEPT BioRobotics Corporation price graph
27 sessions
24 18 12 Aug 18 Sep

The line runs 21 USD on 12 August through 19 USD on 18 September, on a scale from 18 to 24. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
1.1B USD
Revenue, year to Dec 2025
308.1M USD
EPS, diluted, year to Dec 2025
−1.72 USD
52-week range
16.68 USD – 40 USD
Avg volume
86.1K

as of Sep 18, 2026

Have PROCEPT BioRobotics (PRCT) insiders bought or sold shares recently?

In the 90 days to 10 Nov 2026, PROCEPT BioRobotics insiders reported 4 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 7 Aug 2026.

Form 4, 90 days to 10 Nov 2026, newest reported trade 6 Nov 2026

0buys
4sells
$115Knet sold
5other filings
Have PROCEPT BioRobotics (PRCT) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
06 Nov 2026Sharma PoojaChief Strat/Marketing OfficerSell4,71093K USD
09 Sep 2026Nouri AlalehEVP, CLO, CORP. SEC.Sell2976K USD
09 Sep 2026Templin Barry LEVP, Chief Technology OfficerSell3738K USD
09 Sep 2026Waters KevinEVP, CFOSell3738K USD
Sold4 open-market sales5,753$115K
5 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have PROCEPT BioRobotics (PRCT) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
02 Oct 2026Mack MichaelDirectorAward7,727
13 Aug 2026Nouri AlalehEVP, CLO, CORP. SEC.Award22,965
13 Aug 2026Sharma PoojaChief Strat/Marketing OfficerAward23,622
13 Aug 2026Waters KevinEVP, CFOAward29,527
13 Aug 2026Templin Barry LEVP, Chief Technology OfficerAward26,246

Which funds hold PROCEPT BioRobotics (PRCT)?

8 of the 45 institutional funds we track reported a PROCEPT BioRobotics position for the quarter ended 30 Jun 2026 — a combined 40.8M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold PROCEPT BioRobotics (PRCT)?
FundPositionSharesValueShares q/q
Millennium ManagementTrimmed624,31214.1M USD−37.9%
AQR Capital ManagementAdded370,4558.4M USD+44.8%
Marshall WaceTrimmed297,1596.7M USD−57.4%
Man GroupHeld (±25%)254,8455.8M USD−12.7%
Tudor Investment CorpAdded169,7273.8M USD+54.9%
Two Sigma InvestmentsTrimmed51,0031.2M USD−77.7%
Balyasny Asset ManagementTrimmed28,201637K USD−61.9%
Citadel AdvisorsNew position12,612285K USD
Point72 Asset ManagementExited
Renaissance TechnologiesExited

What has been filed or recorded for PROCEPT BioRobotics (PRCT)?

The filings we hold for PROCEPT BioRobotics, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 06 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for PROCEPT BioRobotics (PRCT)?
And
06 Oct 2026Fails to deliverShares failed to deliver4,929 shares88K USD notional · 0.009% of shares out
05 Oct 2026Fails to deliverShares failed to deliver32,037 shares550K USD notional · 0.056% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.46 USDRevenue $98M
30 Sep 2026FinancialsTotal assets473.8M USDat period end
30 Sep 2026FinancialsTotal equity328.9M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.47 USDRevenue $94M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.56 USDRevenue $83M
31 Dec 2025Annual reportFY 2025 reportedEPS −1.72 USDRevenue $308M
31 Dec 2025FinancialsRevenue308.1M USDfiscal year
31 Dec 2025FinancialsNet income−95.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−1.72 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.38 USDRevenue $83M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.35 USDRevenue $79M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.45 USDRevenue $69M
31 Dec 2024Annual reportFY 2024 reportedEPS −1.75 USDRevenue $224M

What do people ask about PROCEPT BioRobotics (PRCT)?

From live data
What did PROCEPT BioRobotics shares close at?19.00

PROCEPT BioRobotics closed at 19.00 USD on 18 Sep 2026, down 2.41% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is PROCEPT BioRobotics’ market cap?1.1B

PROCEPT BioRobotics is worth 1.1B USD by market value as of 18 Sep 2026, which is the share price times the shares on issue from its SEC filings.

What is PROCEPT BioRobotics’ revenue?308.1M

PROCEPT BioRobotics reported revenue of 308.1M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have PROCEPT BioRobotics insiders bought or sold shares recently?4 sales

In the 90 days to 10 Nov 2026, PROCEPT BioRobotics insiders reported 4 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 7 Aug 2026. A further 5 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own PROCEPT BioRobotics?8 of 45

8 of the 45 funds we track reported a PROCEPT BioRobotics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, AQR Capital Management and Marshall Wace. See Funds

When did PROCEPT BioRobotics last report earnings?−0.46

PROCEPT BioRobotics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.46 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings